Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (2): 72-77.doi: 10.6040/j.issn.1673-3770.0.2021.121
Previous Articles Next Articles
WANG Hui1, WANG Jun2, SUN Yi1, YU Tengfei1, ZHU Yuguang2, ZHU Yan2
CLC Number:
[1] 周玮琰, 王洪亚, 杜秀娟, 等. 甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 90-95. doi: 10.6040/j.issn.1673-3770.0.2016.146. ZHOU Weiyan, WANG Hongya, DU Xiujuan, et al. Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(2): 90-95. doi: 10.6040/j.issn.1673-3770.0.2016.146. [2] Sun JK, Jampol LM. The diabetic retinopathy clinical research network(DRCR.net)and its contributions to the treatment of diabetic retinopathy[J]. Ophthalmic Res, 2019, 62(4): 225-230.doi:10.1159/000502779. [3] Tang PH, Hariprasad SM, Do DV. Rethinking management strategies for proliferative diabetic retinopathy[J]. Ophthalmic Surg Lasers Imaging Retina, 2018, 49(4): 224-227. doi:10.3928/23258160-20180329-01. [4] Capitão M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy[J]. J Cell Biochem, 2016, 117(11): 2443-2453. doi:10.1002/jcb.25575. [5] Ezquer M, Urzua CA, Montecino S, et al. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the Retina of diabetic mice[J]. Stem Cell Res Ther, 2016, 7: 42. doi:10.1186/s13287-016-0299-y. [6] Wang LS, Wang H, Zhang QL, et al. Hepatocyte growth factor gene therapy for ischemic diseases[J]. Hum Gene Ther, 2018, 29(4): 413-423. doi:10.1089/hum.2017.217. [7] Country MW. Retinal metabolism: a comparative look at energetics in the Retina[J]. Brain Res, 2017, 1672: 50-57. doi:10.1016/j.brainres.2017.07.025. [8] 刘万智, 陈珺, 樊长春. 康柏西普治疗增生性糖尿病视网膜病变[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 88-91. doi: 10.6040/j.issn.1673-3770.0.2018.005. LIU Wanzhi, CHEN Jun, FAN Changchun. Clinical study of conbercept in the treatment of proliferative diabetic retinopathy[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 88-91. doi: 10.6040/j.issn.1673-3770.0.2018.005. [9] El Rami H, Barham R, Sun JK, et al. Evidence-based treatment of diabetic retinopathy[J]. Semin Ophthalmol, 2017, 32(1): 67-74. doi:10.1080/08820538.2016.1228397. [10] Baker CW, Jiang Y, Stone T. Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network[J]. Curr Opin Ophthalmol, 2016, 27(3): 210-216. doi:10.1097/icu.0000000000000262. [11] Hammes HP, Lin J, Renner O, et al. Pericytes and the pathogenesis of diabetic retinopathy[J]. Diabetes, 2002, 51(10): 3107-3112. doi:10.2337/diabetes.51.10.3107. [12] Yun JH, Park SW, Kim KJ, et al. Endothelial STAT3 activation increases vascular leakage through downregulating tight junction proteins: implications for diabetic retinopathy[J]. J Cell Physiol, 2017, 232(5): 1123-1134. doi:10.1002/jcp.25575. [13] Yun JH, Koh YJ, Jeong HS, et al. Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy[J]. Biochem Biophys Res Commun, 2018, 503(4): 2792-2799. doi:10.1016/j.bbrc.2018.08.041. [14] Yun JH. Hepatocyte growth factor prevents pericyte loss in diabetic retinopathy[J]. Microvasc Res, 2021, 133: 104103. doi:10.1016/j.mvr.2020.104103. [15] Miyagi H, Thomasy SM, Russell P, et al. The role of hepatocyte growth factor in corneal wound healing[J]. Exp Eye Res, 2018, 166: 49-55. doi:10.1016/j.exer.2017.10.006. [16] Cantón A, Burgos R, Hernández C, et al. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy[J]. Br J Ophthalmol, 2000, 84(7): 732-735.doi:10.1136/bjo.84.7.732. [17] Nowak M, Wielkoszyński T, Marek B, et al. A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy[J].Endokrynologia Polska, 2008, 59(1): 2-5. [18] Simó R, Vidal MT, García-Arumí J, et al. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study[J]. Diabetes Res Clin Pract, 2006, 71(1): 36-44.doi:10.1016/j.diabres.2005.05.017. [19] Yun JH. Hepatocyte growth factor prevents pericyte loss in diabetic retinopathy[J]. Microvasc Res, 2021, 133: 104103. doi:10.1016/j.mvr.2020.104103. [20] Zakirova EY, Valeeva AN, Aimaletdinov AM, et al. Potential therapeutic application of mesenchymal stem cells in ophthalmology[J]. Exp Eye Res, 2019, 189: 107863. doi:10.1016/j.exer.2019.107863. [21] Jin ZB, Gao ML, Deng WL, et al. Stemming retinal regeneration with pluripotent stem cells[J]. Prog Retin Eye Res, 2019, 69: 38-56. doi:10.1016/j.preteyeres.2018.11.003. [22] Xu W, Wang XT, Xu GX, et al. Stromal cell-derived factor 1α-stimulated mesenchymal stem cells confer enhanced protection against light-induced retinal degeneration in rats[J]. Curr Eye Res, 2014, 39(1): 69-78. doi:10.3109/02713683.2013.824988. [23] Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP[J]. Biochem Biophys Res Commun, 2001, 282(1): 148-152. doi:10.1006/bbrc.2001.4570. [24] Kim KS, Park JM, Kong T, et al. Retinal angiogenesis effects of TGF-β1 and paracrine factors secreted from human placental stem cells in response to a pathological environment[J]. Cell Transplant, 2016, 25(6): 1145-1157. doi:10.3727/096368915x688263. [25] Mathot F, Shin AY, Van Wijnen AJ. Targeted stimulation of MSCs in peripheral nerve repair[J]. Gene, 2019, 710: 17-23. doi:10.1016/j.gene.2019.02.078. [26] Hei WH, Almansoori AA, Sung MA, et al. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor(BDNF)tohuman umbilical cord blood-derived mesenchymal stem cells(UCB-MSCs)promotescrush-injured rat sciatic nerve regeneration[J]. Neurosci Lett, 2017, 643: 111-120. doi:10.1016/j.neulet.2017.02.030. [27] Fotia C, Massa A, Boriani F, et al. Prolonged exposure to hypoxic milieu improves the osteogenic potential of adipose derived stem cells[J]. J Cell Biochem, 2015, 116(7): 1442-1453.doi:10.1002/jcb.25106. [28] El Barky AR, Ezz AAH, Alm-Eldeen AA, et al. Can stem cells ameliorate the pancreatic damage induced by streptozotocin in rats? [J]. Can J Diabetes, 2018, 42(1): 61-70. doi:10.1016/j.jcjd.2017.04.002. [29] Choi KS, Shin JS, Lee JJ, et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract[J]. Biochem Biophys Res Commun, 2005, 330(4): 1299-1305.doi:10.1016/j.bbrc.2005.03.111. |
[1] | WANG Jiaojiao, LI MiaoOverview,SONG ZongmingGuidance. Progress in diabetic retinopathy mechanisms and cellular models [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 93-99. |
[2] | LIU Zhigao, WANG Shuya, HAN Xuguang, WANG Yu, LI Zhiwei, MA Aihua, ZHAO Bojun. Preoperative timing and the effect of intravitreal aflibercept injection for proliferative diabetic retinopathy patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 99-103. |
[3] | LIU Jianbo, ZHANG Huan. Phacoemulsification combined with intravitreal ranibizumab or triamcinolone acetonide injection for the treatment of cataract accompanied by diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 99-104. |
[4] | LI Baohua, LIU Ping, WANG Xin. Effect of beta elemene on the expression of IL-1 beta and ICAM-1 in the retina of diabetic rats [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 111-114. |
[5] | WANG Xinjuan, SHA Shike, MA Lusheng. A case of transient monocular visual loss after vitrectomy for diabetic retinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 171-172. |
[6] | LIU Wanzhi, CHEN Jun, FAN Changchun. Clinical study of conbercept in the treatment of proliferative diabetic retinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 88-91. |
[7] | ZHOU Xueyi, LI Yiming, WANG Meiju, ZHANG Yuanyuan, ZHANG Lizhuo. The application of 25-gauge minimally invasive vitreoretinal surgery combined with intravitreal ranibizumab injections in the treatment of proliferative diabetic retinopathy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 87-89. |
[8] | . Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(2): 90-95. |
[9] | YAN Xiaoteng, FENG Jun, KANG Xinle. Intravitreal injection of conbercept for macular edema secondary to retinal vein occlusion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 105-108. |
[10] | SHAO Na, ZHANG Han. Variation of visual acuity and fundus in type 2 diabetic patients after phacoemulsification surgery. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 83-87. |
[11] | LI Junying. Effects of rosuvastatin combined with fenofibrate therapy on vascular endothelial function retinopathy diabetic retinopathy patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 72-75. |
[12] | CHAI Xuerong, ZHANG Shixi, TAO Yu, SHEN Jiaquan. Effect of intravitreal ranibizumab injection combined with trabelectomy and panretinal photocoagulation for neovascular glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 72-75. |
[13] | LIU Zhi-gao, YAN Shi-long, HU Zun-xia, SUN Tong-xin, YANG Ming, WANG Yu. Prevalence investigation on rural cataract patients with diabetes and diabetes retinal fundus lesions in Jinan city of Shandong province [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(1): 38-39. |
[14] | LIU Hai-yang, LI Su-yan, ZHANG Zheng-pei, FAN Wei. Comparison of improved membrane dissection and bimanual enbloc excision in 23G vitrectomy to treat proliferative diabetic retinopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(1): 52-55. |
[15] | MA Dong, GUO Cheng-wei. Collaterals therapy influences the expression of VCAM-1 in the retinal capillary wall of STZ-induced diabetic rats [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(1): 64-68. |
|